Inflammation-Related Gene ADH1A Regulates the Polarization of Macrophage M1 and Influences the Malignant Progression of Gastric Cancer
Jun Ma,Yongkang Shi,Qiliang Lu,Dongsheng Huang
DOI: https://doi.org/10.2147/jir.s452670
IF: 4.5
2024-07-13
Journal of Inflammation Research
Abstract:Jun Ma, 1 Yongkang Shi, 1 Qiliang Lu, 1 Dongsheng Huang 2 1 General Surgery, Cancer Center, Department of Gastrointestinal and Pancreatic Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China; 2 Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, People's Republic of China Correspondence: Dongsheng Huang, Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, No. 158 Shangtang Road, Gongshu District, Hangzhou, Zhejiang, 310014, People's Republic of China, Tel/Fax +86-571-88927749, Email Background: Gastric cancer (GC) is a malignant tumor originating from the gastric mucosa epithelium, and there is a low survival rate of GC patients after treatment, with a poor prognostic outcome. The inflammatory response within the tumor microenvironment plays an important role in GC progression. Methods: We downloaded GC-related datasets and inflammation-related genes from GEO, TCGA and MSigDB databases, performed differential analysis, protein-protein interaction analysis, immunoinfiltration analysis and Lasso analysis to screen inflammation-related hub genes affecting GC progression, and carried out qRT-PCR for validation. In order to explore the role of ADH1A, we constructed overexpressed plasmids, treated GC cells with cGMP/PKG pathway agonist 8-Br-cGMP, and tested cell functions with CCK8, EdU, Transwell, scratch assay and other experiments. On this basis, GC cells were co-cultured with monocyte THP-1 to explore the effect of ADH1A on the polarization of macrophages. Results: ADH1A was significantly decreased in GC cells, and its expression trend was consistent with the results of bioinformatics analysis. Therefore, we chose ADH1A for subsequent functional validation. Overexpression of ADH1A in GC cells revealed ADH1A's role in inhibiting the activity, proliferation, migration and invasion of GC cells, promoting apoptosis and secretion of IL-6, IFN-γ, CCL5 and CSF2, and facilitating the transformation of macrophages to a pro-inflammatory M1 phenotype. ssGSEA results demonstrated the potential involvement of ADH1A in the cGMP/PKG signaling pathway, and significant changes in the expression of proteins related to the cGMP/PKG signaling pathway. The use of the cGMP/PKG signaling pathway agonist 8-Br-cGMP in ADH1A-overexpressing GC cells substantiated ADH1A's capacity to inhibit the cGMP/PKG signaling pathway, thereby suppressing the malignant progression of GC and promoting the transformation of macrophages to a pro-inflammatory M1 phenotype. Conclusion: ADH1A is able to influence the malignant progression of GC and the transformation of macrophages to the pro-inflammatory M1 phenotype through the cGMP/PKG signaling pathway. Keywords: gastric cancer, inflammation, immune infiltration analysis, ADH1A, cGMP/PKG signaling pathway Gastric cancer (GC) is the world's fifth most common malignant tumor, posing a significant global health concern. Diagnosed typically at an advanced stage, patients with GC have a high mortality rate, which ranks GC as the third leading cause of cancer-related deaths, 1 with an extremely low 5-year survival rate. 2 Helicobacter pylori infection is the main cause and one of the major risk factors of GC, 3 despite declining infection rates due to economic development and improved living standards. Unhealthy dietary habits, including high salt, fat and cholesterol intake, contribute to elevated GC risk. 4 While familial aggregation is observed in GC cases, only 1–3% demonstrate autosomal dominant inheritance. 5 In addition, hormonal factors, particularly estrogen, contribute to the male predominance in GC cases. 6 Screening initiatives, notably in Japan and South Korea, have significantly reduced cancer-related mortality. 1 Therefore, exploring disease markers for GC is crucial for its early intervention and progression assessment, which in turn prevent its potential malignant progression and metastasis. Inflammation is considered a critical cancer marker, and it is beneficial for fostering a conducive environment for tumor cell growth, invasion and metastasis through the secretion of various inflammatory mediators. During inflammation-induced tumorigenesis, the pro-tumor immune effect outweighs the anti-tumor immune effect in the tumor microenvironment. Therefore, immunotherapy has emerged as a -Abstract Truncated-
immunology